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Abstract  
Introduction: Hepatitis B Virus, a highly infectious blood-borne virus poses a major threat to public health globally due to its high prevalence rate 
and grave consequence in causing liver cirrhosis and hepatocelullar carcinoma, the third cause of cancer death worldwide. The aim is determine 
the prevalence of HBsAg, knowledge, and vaccination practices against viral hepatitis B infection among doctors and nurses in a health care 
facility. Methods: Study design was a descriptive cross-sectional study among all the doctors and nurses in the health care facility. Data was 
collected using pre-tested, structured, self-administered questionnaire and blood samples were taken from respondents and tested using 
commercial enzyme-linked immunosorbent assay (ELIZA) test kit to determine prevalence of hepatitis B surface antigen after informed consent. 
Ethical approval was obtained from Health Research and Ethics Committee of the Lagos University Teaching Hospital. Responses of the 
respondents to the knowledge and vaccination practices against viral hepatitis B infection were scored and graded as poor (<50%), fair (50-74%) 
and good (≥75%). The study was carried out in January, 2014. Results: A total of 134 out of the 143 recruited respondents participated in the 
study. Prevalence of HBsAg was 1.5%. Among the respondents, 56.7% had good knowledge and 94.8% reported poor practice of vaccination 
against viral hepatitis B infection. Mean knowledge and vaccination practices scores (%) were 72.54+7.60 and 29.44+14.37 respectively. Only 
29% of the respondents did post vaccination testing for anti HBsAg. Conclusion: Prevalence of HBsAg was low. Knowledge of viral hepatitis B was 
fair, and practice of post hepatitis B vaccination testing was poor. It is therefore recommended that the state ministry of health should organise 
further health education programme, institute compulsory occupational hepatitis B vaccination programme and post vaccination anti-HBS testing to 
ensure adequate antibody level in this adult population. 
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HBV, a highly infectious blood-borne virus, is responsible for about 
80% of all cases of hepatocelullar carcinoma, which is the third 
leading cause of cancer death in Asia and Africa [1]. Hepatitis B 
Virus has been estimated to infect more than 2 billion people 
globally due to its endemicity; 350million of these people are 
chronically infected and become carriers of the virus and 10-
30million will become infected annually. An estimate of more than 
1million die annually, while approximately 2 people die each minute 
from HBV infection [2-5]. About a quarter of the chronic carriers will 
later die from hepatic complications. While some remain life-long 
carriers, others will clear the infection after varying interval [2, 6]. 
The prevalence of HBV infection varies, depending on a number of 
factors which includes the geographical region, host factors as well 
as other environmental/behavioural factors. A larger percentage of 
areas of North America have a low prevalence (<2%). This low 
prevalence could be attributed to the high standard of living in these 
areas, although some high prevalence pockets exist, particularly in 
areas with a high proportions of Asian immigrants, Alaskan and 
northern Canadian native populations, where rates as high as 5% - 
15% of chronic HBV or prevalence of HbsAg positivity are found 
[3,7]. The acquisition of HBV infection in most of these low 
prevalence regions occur mainly during adolescence and mid-
adulthood [2]. India has intermediate endemicity of Hepatitis B with 
a prevalence of hepatitis B surface antigen (HBsAg) between 2% 
and 7%. The number of HBsAg carriers in India has been estimated 
to be over 50 millions [1]. Studies done in Nigeria showed HBV 
carriage rate in the range of 9-39% [8]. In a study done among 
surgeons in Nigeria, the prevalence of HBsAg among the doctors 
(surgeons) was 25.7%, the prevalence of anti-HBs was 22.2% in 
the doctors and that of antiHBc was 61.7% in the doctors, while no 
HBV marker was detected in 23.4% of the doctors [9]. HBV is a 
priority occupationally acquired infection that is associated with 
serious public and personal health consequences, and is considered 
to be the most important cause of occupational acquired viral 
hepatitis amongst doctors and nurses who are particularly exposed 
via contact with blood and secretions in the course of discharging 
their duty [3,4]. The risk of acquiring HBV in these cadres of health 
workers is four times greater than that of the general population 
[10]. An estimate of about 600,000-800,000 cuts and puncture 
injuries occur in them annually, out of which approximately 50% are 
not registered [11]. Hepatitis B is a vaccine preventable disease, 
though a sizeable proportion of HCWs never get vaccinated. Both 
the pre-exposure and post-exposure administration of the vaccines 
have been recommended [2,12]. This has been a major reason for 
advocating compulsory vaccination against HBV among health care 
workers before being exposed to patients to prevent serious 
consequences including long term illness, debility and death [13]. 
Therefore, doctors and nurses should be aware of the risks involved 
in treatment procedures, and should endeavour to take due 
precautions in dealing with patients, since knowing facts and having 
proper attitudes are very crucial to prevent the prevalence and 
spread of HBV, or its reduction to the barest minimum [11]. This 
study was therefore carried out to determine the prevalence of 
HBsAg, knowledge and vaccination practices against viral hepatitis B 






Study Location: the study was carried out in Lagos Island 
Maternity Hospital, located in Lagos Island, an urban community of 
Lagos state in South Western, Nigeria. The Hospital, a 500-bed 
secondary health care facility for Obstetrics and Gynaecology cases, 
served as a referral centre to other health centres and other general 
hospitals from neighbouring towns both within and outside Lagos 
state. The hospital benefited from the occupational hepatitis B 
vaccination programme carried out by the Lagos state government 
[14]. There were 48 doctors and 95 nurses in the hospital at the 
time of the study. 
Methods: the study design was a descriptive cross-sectional study 
among doctors and nurses in Lagos Island Maternity Hospital. With 
a confidence interval of 95%, degree of accuracy desired of 5%, 
and prevalence of HBsAg in a previous study [9] of 25.7%, the 
minimum sample size of 107 was determined using the formula for 
descriptive cross-sectional study when sampled population is less 
than 10,000. However, all the 143 doctors and nurses (48 doctors 
and 95 nurses) in the hospital were enrolled into the study. The 
study was carried out in January 2014. A pre-tested, structured, 
self-administered questionnaire which was derived from other 
similar published studies [15-17] was used to collect information on 
socio-demographic characteristics, knowledge of HBV infection and 
practice of hepatitis B vaccination. Each correct response to the 
knowledge and vaccination practice questions was scored one mark 
and any wrong or non response was scored zero. The total score 
obtained by each respondent was converted to percentage and 
graded as poor (<50%), fair (50-74%) and good (≥75%). The 
mean knowledge and practice scores (%) for all the respondents 
were also calculated. Laboratory technique using commercial 
enzyme-linked immunosorbent assay (ELIZA) kits was used to 
determine prevalence of hepatitis B surface antigen. Sample with 
cut-off index greater than or equal to 1.0 was considered positive 
for HBsAg. 
Data analysis: data analysis was done using Epi-info version 3.5.1, 
WinPepi and GraphPad Instat statistical software packages. Chi-
square and Fisher's exact tests were used to compare differences 
between proportions while t-test and analysis of variance (ANOVA) 
were used to compare differences between means. P value ≤0.05 
was considered statistically significant. 
Ethical Issues: ethical approval was obtained from Health 
Research and Ethics Committee (HREC) of the Lagos University 
Teaching Hospital (LUTH). Verbal informed consent was obtained 





Response rate: a total of 134 out of the 143 doctors and nurses 
participated in the study, giving a response rate of 93.7%. Socio-
demographic characteristics of the respondents: The mean age of 
the respondents was 35.86+8.61 years. Majority of the respondents 
were females (72.39%), Christians (74.63%), nurses (64.93%), 
unmarried (59.70%) and had spent less than 10years on their 
current job (82.84%) (Table 1). 
 
Prevalence of HbsAg: only 2(1.5%) of the respondents were 
found positive for HBsAg. Among the respondents who were HBsAg 
seropositive, 1(50.0%) was a male, and 1(50.0%) was a female; 
1(50.0%) was a nurse and 1(50.0%) was a doctor by profeesion; 
the 2 were Christians (100.0%), married (100.0%) and 1(50.0%) 
had spent less than 10 years on current job. There was no 
statistically significant relationship (p>0.05) between the 
sociodemographic characteristics and viral hepatitis B Serostatus 
(Table 1). Knowledge of viral Hepatitis B: Majority of the 
respondents (56.70%) had good knowledge while 43.30% had fair 
knowledge of hepatitis B infection although, there were observed 
gaps: Over a third (34.3%) of the respondents knew that a person 
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who has recovered from viral hepatitis B does not transmit the 
virus; only 32.8% of the respondents knew that hepatitis B vaccine 
has no effect on HBsAg carriers; and only 30.6% of the respondents 
knew that both pre-exposure and post-exposure administration of 
hepatitis B vaccine is recommended. The mean knowledge score 
(%) which suggests the depth of knowledge on the aspects of 
knowledge investigated was 72.54+7.60 (Table 2). There was no 
statistically significant relationship (p>0.05) between the 
sociodemographic characteristics and knowledge of viral hepatitis B 
infection (Table 3). 
 
Practice of hepatitis B vaccination: Majority (94.8%) of the 
respondents reported poor practice while 5.2% reported fair 
practice of hepatitis B vaccination: 22.4% did not receive any dose 
of hepatitis B vaccine, 11.9% received 1 dose of hepatitis B vaccine, 
17.2% received 2 doses of hepatitis B vaccine, and 48.5% received 
the complete 3 doses of hepatitis B vaccine. About one-third (29%) 
of the respondents checked their immunity against hepatitis B after 
vaccination, while only 23.9% of the respondents found out they 
were protected after receiving the complete 3 doses of hepatitis B 
vaccine. Respondents also gave reasons for not being vaccinated: 
0.7% said that the vaccine was too expensive, 1.5% said the 
vaccine was not available, 0.7% said they were scared because the 
vaccine hurts while 19.4% gave no reason. The mean practice score 
(%) which suggests the depth of practice of hepatitis B vaccination 
on the aspects of practice investigated was 29.4+14.4. There was 
statistically significant relationship (p=0.046) between occupation of 
respondents and practice of hepatitis B vaccination (Table 4). 
There was also no statistically significant relationship (p>0.05) 
between any of the socio-demographic characteristics and number 





Prevalence of Hepatitis B Surface Antigen: The finding that 
only 1.5% of the respondents were positive for HBsAg is lower than 
the findings of 25.7% among surgeons in a study carried out in 
Lagos [9] but is similar to the findings of 2.18% and 2.4% from the 
studies conducted in Peshawar, Pakistan [18] and Korea [19] 
respectively. The low prevalence of HBsAg in this study may be 
attributed to the increased awareness of viral Hepatitis B infection 
and high prevalence of prior vaccination in the subjects. 
Furthermore, since screening for HBSAg is done before any 
vaccination is commenced; those who were seropositive might have 
been transferred to administrative units in the state ministry of 
health. 
  
Knowledge of Viral Hepatitis B: The finding that all the 
respondents had good basic knowledge of viral hepatitis B could be 
due to the hepatitis B vaccination programme organized for health 
workers by the Lagos state government. There was a dearth of 
deeper knowledge and understanding however as less than 35% 
were familiar with HBV immunology and the long lasting implications 
of resolved HBV infection. This is similar to findings from other 
studies done in U.S.A and Australia, among middle and high grade 
medical doctors; studies done in China and Iran among surgeons; 
and among healthcare workers in Karachi (Pakistan), where the 
respondents demonstrated a very low knowledge of hepatitis B 
infection [20-23]. This study is quite encouraging considering the 
fact that knowledge is usually the first step towards modification of 
a desirable behaviour. Modes of transmission of viral Hepatitis B 
include parenteral route, perinatal transmission, and sexual 
transmission, transmission from child-to-child (horizontal 
transmission) through physical contact between children with skin 
conditions such as impetigo and scabies or with cuts or grazes. 
Transmission by blood sucking arthropods is suspected but there is 
no convincing evidence to support this suggestion [2]. In this study, 
the knowledge of the respondents about the various aspects of 
transmission of viral hepatitis B was generally high although there 
was observed gap; only 34.5% of the respondents knew that a 
person who has recovered from viral hepatitis B does not transmit 
the virus. This finding is at variance with the findings from the 
studies carried out in USA, Australia, Pakistan, China and Iran which 
revealed that the knowledge about the transmission of viral 
hepatitis B was low [20,21]. The low knowledge of transmission of 
viral Hepatitis B infection in USA, Australia, China and Iran might be 
because these countries are not viral Hepatitis B endemic areas. 
This study revealed that all the respondents knew that viral hepatitis 
B can be transmitted through blood transfusion, 97% knew it can be 
transmitted through needle stick injuries (NSIs) and 91% knew it 
can be transmitted through sexual intercourse. These findings are 
higher than the findings from a study carried out in Karachi among 
health care workers in a tertiary hospital where 95% of the 
respondents knew that viral hepatitis B can be transmitted through 
blood transfusion, 92% knew it can be transmitted through NSIs 
and 78% knew it can be transmitted through sexual intercourse 
[23]. The findings in our study are also higher than the findings 
from a study among health workers in southern Nigeria where 
68.5% knew viral hepatitis B can be transmitted through NSIs and 
37% knew it can be transmitted through sexual intercourse [24]. 
High risk groups comprise the of blood transfusions, health care and 
laboratory personnel, homosexuals, prostitutes, percutaneous drug 
abusers, infants of HBV carrier mothers and mothers who are 
immuno-compromised [2]. In this study, the finding that 91% of the 
respondents knew that healthcare workers (HCWs) are at risk is 
higher than the finding in Karachi study which reported that 65% of 
the respondents knew that all HCWs are at risk [23]. The difference 
might be due to the fact that the Karachi study was carried out 
among doctors, medical students and paramedical staff. In this 
study, 91% of the respondents were aware that HBV can be 
transmitted from patients to HCWs and 98.5% knew that the virus 
can be transmitted from HCWs to patients. These findings are 
higher than the findings in the study carried out in Kuwait among 
HCWs in primary health care centres where more than three 
quarters of the respondents (76.2%) were aware that HBV can be 
transmitted from patients to HCWs and 57.7% knew that the virus 
can be transmitted from HCWs to patients [17]. It is also higher 
than the finding from a study carried out among HCWs in Southern 
Nigeria where 80.9% of the respondents reported that viral hepatitis 
B can be acquired as nosocomial infection [24]. Since there is no 
specific curative treatment, prevention has been the major aim in 
managing viral hepatitis B. One of the preventive measures is 
administration of hepatitis B vaccine. The plasma derived vaccine is 
based on the surface antigen (HbsAg) which is harvested and 
purified from the plasma of human carriers of hepatitis B virus. The 
vaccine is given in 3 doses. An effective antibody response is 
attained after 3 doses in 95% of vaccines. In this study, 82.1% of 
the respondents were aware that three doses of Hepatitis B vaccine 
are required for complete vaccination whereas only 65.7% knew the 
correct interval between the doses. This is higher than the findings 
from a study carried out in Kuwait among HCWs in a primary health 
care centre which revealed that 65.9% of the respondents were 
aware about the number of doses of vaccination required for 
complete protection, whereas only 44.4% answered correctly about 
expected interval between the doses [17]. The finding in this study 
that 74.6% of the respondents knew that vaccination provides 
protection due to an effective antibody response which is generally 
attained after 3 doses in 95 percent of vaccinees is lower than the 
finding from the Karachi study in which 89% of the respondents 
believed that vaccination provides protection [23]. 
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Practice of Viral Hepatitis B vaccination: in this study, 11.9%, 
17.2% and 48.5% of the respondents had received 1 dose, 2 doses 
and complete 3 doses of HBV vaccine respectively. The finding that 
only 11.9% of the respondents had received only 1 dose of hepatitis 
B vaccine is lower than the finding of 40.6% from the study 
conducted in Egypt [25]. The finding that 77.6% of the respondents 
in this study had received at least one dose of Hepatitis B vaccine, 
contrasts the findings of the studies carried out in Iran (93.3%) 
[26], Kenya (47.5%, 12.8%) [27, 28], South Africa (21.2%) [29] 
and southern Nigeria (70.2%) [24]. In this study, only 29% of the 
respondents checked their immunity status against viral hepatitis B, 
this is at variance with the findings of the study conducted in Iran 
which reported that 56.8% had checked their antibody levels [26] 
and the study conducted in Kenya which revealed that none of the 
respondents had previously checked their immunity status against 
hepatitis B [28]. This is particularly important in sub-Saharan Africa 
where most viral Hepatitis B infections are acquired in childhood. In 
these places, adult vaccination especially in health care workers 
should be accompanied by evaluation of protective anti HBs titres 
post vaccination. The practice of post vaccination antibody testing 
noted in this study, while consistent with reports from Kenya and 
Pakistan, is at variance reports from Johannesburg, South Africa 
[29] where up to 45% of HCW performed post vaccination testing. 
This may be related to the socio-economic characteristics of the 
studied population, the test availability and the availability of 





In conclusion, Prevalence of HBsAg was low; knowledge of basic 
viral hepatitis B infection was good while knowledge of HBV 
immunology was poor. Practice of hepatitis B vaccination was poor. 
It is therefore recommended that the state ministry of health should 
organise HBV training and education for HCWs. The ministry should 
also institute compulsory occupational hepatitis B vaccination 
programme and post vaccination anti-HBS testing to ensure 
adequate antibody level in this adult population. 
 
What is known about this topic 
 
• Prevalence of hepatitis B surface antigen is relatively high 
among health care workers (doctors and nurses) in 
Nigeria. 
 
What this study adds 
 
• We found prevalence of hepatitis B surface antigen is low 
among the doctors and nurses; 
• We found Knowledge of HBV immunology is poor among 
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Table 1: distribution of respondents by sociodemographic characteristics according to hepatitis B 
Serostatus  
Socio-demographic Hepatitis B Serostatus Frequency (%) 
Statistics and 
Pvalue 




      
20-29 41(31.06) 0  (0.00) 41(30.60) 
 
30-39 50(37.88) 1 (50.00) 51(38.06) 
 
40-49 34(25.76) 1 (50.00)) 35(26.12) 
 
50-59 7(5.30) 0(0.00) 7(5.22) 
 
Total 132(100.00) 2(100.00) 134(100.00) 
 
Mean + SD 35.81+8.63 39.00+8.49 35.86 + 8.61 




      
Male 36(27.27) 1(50.00) 37(27.61) X2=0.509 
Female 96(72.3) 1(50.00) 97(72.39) df=1 
Total 132(100.00) 2(100.00) 134(100.00) p=0.098 
Occupation 
 
      
Doctors 46(34.85) 1(50.00) 47(35.07) X2=0.199 
Nurses 86(65.15) 1(50.00) 87(64.93) df=1 
Total 132(100.00) 2(100.00) 134(100.00) p=0.656 
Religion 
 
      
Christianity 98(74.24) 2(100.00) 100(74.63) X2=0.69 
Islam 34(25.76) 0(0.00) 34(25.37) df=1 
Total 132(100.00) 2(100.00) 134(100.00) p=0.406 
Marital status 
 
      
Not married 80(60.61) 0(0.00) 80(59.70) X2=3.0079 
Married 52(39.39) 2(100.00) 54(40.30) df=1 
Total 132(100.00) 2(100.00) 134(100.00) p=0.083 
Years of experience 
 
      
Less than 10yrs 110(83.33) 1(50.00) 111(82.84) 
 
10yrs and above 22(16.67) 1(50.00) 23(17.16) 
 
Total 132(100.00) 2(100.00) 134(100.00) 
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Table 2: respondents’ knowledge of viral hepatitis B infection 




Prevention and containment 
 
Hepatitis B vaccine 
 
Three doses of Hepatitis B vaccine are required for complete protection 110(82.1) 
An effective antibody response is generally attained after 3 doses in 95 percent of 
vaccinees. 
100(74.6) 
First dose is given at elected date, second dose is given 1 month after 1st dose while 3rd 
dose is given 6 months after the 1st dose 
88(65.7) 
Immunity continues at protective levels for approximately 3-5 years after vaccination 73(54.5) 
Patients who are vaccinated against hepatitis B should not be considered as a possible 
source of hepatitis B infection 
68(50.7) 
Hepatitis B vaccine has no effect on HBsAg carriers 44(32.8) 
Both pre-exposure and post-exposure administration of hepatitis B vaccine is 
recommended 
41(30.6) 
• Other measures •  
Proper needles/sharps disposal can prevent viral Hepatitis B 122(91.0) 
All blood donors should be screened for HBV infection and those positive for Australian 
















































































































Table 3: association between socio-demographic characteristics and Knowledge of 
viral hepatitis B 
Socio-demographic 
Knowledge of viral hepatitis 
B Frequency (%) 
Statistics and 
Pvalue 




    
20-29 21(51.2) 20(48.8) 
 
30-39 20(39.2) 31(60.8) 
 
40-49 14(40.0) 21(60.0) 
 
50-59 3(42.9) 4(57.1) 
 
Total 58(43.3) 76(56.7) 
 
Mean + SD 34.86+9.05 36.62+8.23 




    
Male 18(48.7) 19(51.3) 
 
Female 40(41.24) 57(58.8) 
X2 =0.599; df=1; 
p=0.438 




    
Doctors 20(42.6) 27(57.4) 
 
Nurses 38(43.7) 49(56.3) 
X2 =0.016; df=1; 
p=0.900 




    
Christianity 44(44.0) 56(56.0) 
 
Islam 14(41.2) 20(58.8) 
X2 =0.082; df=1; 
p=0.774 




    
Not married 38(47.5) 42(52.5) 
 
Married 20(37.0) 34(63.0) 
X2 =1.043; df=1; 
p=0.307 
Total 58(43.3) 76(56.7) 
 
Years of experience 
 
    
Less than 10yrs 49(44.1) 62(55.9) 
 
10yrs and above 9(39.1) 14(60.9) 
 
Total 58(43.3) 76(56.7) 
 
Mean+SD 4.16+5.00 5.86 +5.65 
t=1.82; df=132; 
p=0.071 
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Table 4: association between socio-demographic characteristics and Practice of hepatitis B vaccination 
Socio-demographic 
Practice of hepatitis B vaccination 
Frequency (%) 
Statistics and P 
value 




    
20-29 38  (92.7) 3(7.3) 
 
30-39 48  (94.1) 3(5.9) 
 
40-49 34  (97.1) 1(2.9) 
 
50-59 7    (100.0) 0(0.0) 
 
Total 127(94.8) 7(5.2) 
 
Mean + SD 36.17+8.52 30.29+8.86 




    
Male 37  (100.0) 0(0.0) 
 
Female 90  (92.8) 7(7.2) 
X2 =2.817; df=1; 
p=0.093 




    
Doctors 47  (100.0) 0(0.0) 
 
Nurses 80  (92.0) 7(8.0) 
X2 =3.99; df=1; 
p=0.046 




    
Christianity 93  (93.0) 7(7.0) 
 
Islam 34  (100.0) 0(0.0) 
X2 =2.51; df=1; 
p=0.113 




    
Not married 74  (92.5) 6(8.0) 
 
Married 53  (98.1) 1(1.9) *p=0.24 
Total 127(94.8) 7(5.2) 
 
Years of experience 
 
    
10yrs and above 22  (95.7) 1(4.3) 
 
Less than 10yrs 105(94.6) 6(5.4) 
 
Total 127(94.8) 7(5.2) 
 
Mean+SD 5.2 +5.49 3.5+4.27 
t=0.81; df=132; 
p=0.42 














































Table 5: association between Socio-demographic characteristics and number of doses of hepatitis B vaccine received 
Sociodemographic Vaccine Doses Statistics 
Characteristic 0 Dose 1 Dose 2 Doses 3 Doses and P value 
Age-grp(yrs) 
 
      
20-29 4  (9.8) 9  (22.0) 9  (22.0) 19(46.3) 
 
30-39 16(31.4) 4  (7.8) 9  (17.6) 22(43.1) 
 
40-49 9  (25.7) 2  (5.7) 5  (14.3) 19(54.3) 
 
50-59 1  (14.3) 1  (14.3) 0  (0.0) 5  (71.4) 
 
Total 30(22.4) 16(11.9) 23(17.2) 65(48.5) 
 





        
Male 8  (21.6) 4(10.8) 8  (21.6) 17(45.9) x2=0.73 
Female 22(22.7) 12(12.4) 15(15.5) 48(49.5) df=3 
Total 30(22.4) 16(11.9) 23(17.2) 65(48.5) p=0.87 
Religion 
 
        
Christianity 24(24.0) 8(8.0) 16(16.0) 52(52.0) x2=6.88 
Islam 6(17.6) 8(23.5) 7(20.6) 13(38.2) df=3 
Total 30(22.4) 16(11.9) 23(17.2) 65(48.5) p=0.08 
Occupation 
 
        
Doctor 8(17.0) 7(14.9) 13(27.7) 19(40.4) x2=7.08 
Nurse 22(25.3) 9(10.3) 10(11.5) 46(52.9) df=3 
Total 30(22.4) 16(11.9) 23(17.2) 65(48.5) p=0.07 
Marital Status 
 
        
Not married 16(20.0) 10(12.5) 14(17.5) 40(50.0) x2=0.66 
Married 14(25.9) 6  (11.1) 9  (16.7) 25(46.3) df=3 
Total 30(22.4) 16(11.9) 23(17.2) 65(48.5) p=0.88 
Years of experience 
 
        
Less than 10yrs 22(19.8) 15(13.5) 20(18.0) 54(48.6) 
 
10yrs and above 8(34.8) 1(4.3) 3(13.0) 11(47.8) 
 
Total 30(22.4) 16(11.9) 23(17.2) 65(48.5) 
 
Mean + SD 6.98+6.04 4.22+5.72 4.46+4.55 4.72+5.27 
p=0.20 
(ANOVA) 
